Intrinsic biventricular dysfunction in Marfan syndrome
Abstract
Background: Marfan syndrome (MFS) is an autosomal, dominantly inherited, connective tissue disorder usually caused by a mutation in the fibrillin-1 gene (FBN1). As fibrillin-1 is a component of the extracellular matrix of the myocardium, mutations in FBN1 may cause impairment of ventricular function. Furthermore, aortic elasticity is decreased in patients with MFS, which might also impair ventricular function. We assessed biventricular function and the influence of aortic elasticity in patients with MFS by means of cardiac MRI. Methods and results: Cardiac magnetic resonance was performed in 144 patients with MFS without significant valvular dysfunction, previous cardiac surgery or previous aortic surgery. Biventricular diastolic and systolic volumes were measured, and ejection fractions were calculated. Flow wave velocity, a measurable derivative of aortic elasticity, was measured between the ascending aorta and the bifurcation. When compared to healthy controls (n=19), left ventricular ejection fraction (LVEF) was impaired in patients with MFS (53%±7% vs 57%±4%, p<0.005), as was right ventricular ejection fraction (RVEF) (51%±7% vs 56%±4%, p<0.005). LVEF and RVEF were strongly correlated. (r=0.7, p<0.001). No significant differences were found between patients with β-blocker treatment and those without. There was no correlation between aortic elasticity as measured by flow wave velocity and LVEF. Conclusions: Biventricular ejection fraction was impaired in patients with MFS, and the impairment was independent of aortic elasticity and β-blocker usage. There was also a strong correlation between LVEF and RVEF. Our findings suggest intrinsic myocardial dysfunction in patients with MFS. Clinical trial registration: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1423. Unique Identifier: NTR1423Keywords
This publication has 39 references indexed in Scilit:
- Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndromeArchives of Cardiovascular Diseases, 2010
- Validation and reproducibility of aortic pulse wave velocity as assessed with velocity‐encoded MRIJournal of Magnetic Resonance Imaging, 2009
- Tissue Doppler imaging identifies myocardial dysfunction in adults with marfan syndromeClinical Cardiology, 2007
- Left Ventricular Diastolic Dysfunction in Children and Young Adults with Marfan SyndromePediatric Cardiology, 2006
- Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady‐state free precession imaging sequencesJournal of Magnetic Resonance Imaging, 2003
- Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imagingEuropean Radiology, 2000
- Revised diagnostic criteria for the Marfan syndromeAmerican Journal of Medical Genetics, 1996
- Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndromeThe American Journal of Cardiology, 1994
- Spatial arrangements of microfibrils in myocardial scars: Application of antibody to fibrillinJournal of Molecular and Cellular Cardiology, 1990
- Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndromeThe American Journal of Cardiology, 1989